SCHEMBL471846

SCHEMBL471846

O=c1oc2cccc(O)c2c(O)c1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 3/20 0.52
CYP3A4 P08684 5/20 0.50
MAPT P10636 5/20 0.50
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
HPGD P15428 3/20 0.50
ALOX15 P16050 3/20 0.50
MAPK1 P28482 3/20 0.50
KDM4E B2RXH2 3/20 0.50
HSD17B10 Q99714 2/20 0.50
EGFR P00533 1/20 0.50
USP2 O75604 1/20 0.50
LMNA P02545 1/20 0.50
TP53 P04637 1/20 0.50
AR P10275 3/20 0.46
ALDH1A1 P00352 1/20 0.46
CYP1A1 P04798 1/20 0.46
CYP1A2 P05177 1/20 0.46
PKM P14618 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31457155 1.00 MAOA (0.52) MAOACYP3A4MAPTMEN1KMT2A
Sulfuric Acid SCHEMBL4659424 0.93 MAOA (0.46) MAOACYP3A4MAPTMEN1KMT2A
SCHEMBL25370680 0.82 KDM4E (0.61) MAOACYP3A4MAPTMEN1KMT2A
SCHEMBL3062866 0.82 KDM4E (0.51) MAOACYP3A4MAPTMEN1KMT2A
SCHEMBL7797188 0.80 CA12 (0.48) MAOACYP3A4MAPTMEN1KMT2A
SCHEMBL8489954 0.78 NQO1 (0.50) MAOACYP3A4MAPTMEN1KMT2A
SCHEMBL7963729 0.78 NQO1 (0.50) MAOACYP3A4MAPTMEN1KMT2A
SCHEMBL8497467 0.78 MAOA (0.52) MAOACYP3A4MAPTMEN1KMT2A
SCHEMBL11479865 0.78 CYP3A4 (0.58) MAOACYP3A4MAPTMEN1KMT2A
SCHEMBL7406498 0.78 NQO1 (0.68) CYP3A4MAPTMEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102846598-A Application of coumarin in preparing formation inhibitors of advanced glycation end products (AGEs) GUANGZHOU KANGCHENG PHARMACEUTICAL RES CO LTD 2013-01-02 CN claimed
US-8058326-B2 Fluorescent poly(alkylene terephthalate) compositions E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-11-15 US claimed
US-20090146106-A1 FLUORESCENT POLY(ALKYLENE TEREPHTHALATE) COMPOSITIONS E. I. DU PONT DE NEMOURS AND COMPANY 2009-06-11 US claimed
WO-2006041523-A1 FLUORESCENT POLY(ALKYLENE TEREPHTHALATE) COMPOSITIONS E.I. DUPONT DE NEMOURS AND COMPANY (US) 2006-04-20 WO claimed
US-20060041039-A1 Fluorescent poly(alkylene terephthalate) compositions E. I. DU PONT DE NEMOURS AND COMPANY 2006-02-23 US claimed
EP-1448543-A1 PRODUCTS OF CONDENSATIONS OF HYDROXYCOUMARIN DERIVATIVES WITH AROMATIC AND ALIPHATIC DIALDEHYDES, THEIR PREPARATION AND ANTIVIRAL ACTION THEREOF PLIVA-ISTRAZIVACKI INSTITUT d.o.o. (HR) 2004-08-25 EP claimed
US-6660767-B2 Such as coumarin, dicoumarol, 7-hydroxycoumarin (umbelliferone), 6,7- dihydroxycoumarin (exculetin), 3,6,7 trihydroxycoumarin, warfarin, or warfarin sodium; for treatment of cancer, Alzheimer's diseade, gout THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2003-12-09 US claimed
WO-2003029237-A1 PRODUCTS OF CONDENSATIONS OF HYDROXYCOUMARIN DERIVATIVES WITH AROMATIC AND ALIPHATIC DIALDEHYDES, THEIR PREPARATION AND ANTIVIRAL ACTION THEREOF PLIVA, FARMACEUTSKA INDUSTRIJA, DIONICKO DRUSTVO (HR) 2003-04-10 WO claimed
CN-110819665-B Preparation method of 6,7,8-trihydroxy coumarin 苏州大学 2023-02-24 CN disclosed
CN-111803492-B Application of coumarin compound in preparation of medicine for treating hepatitis B 苏州大学 2022-03-29 CN disclosed
CN-110337357-B Thermoplastic resin film and method for producing thermoplastic resin film 富士胶片株式会社 2021-12-10 CN disclosed
CN-111803492-A Application of coumarin compound in preparation of medicine for treating hepatitis B 苏州大学 2020-10-23 CN disclosed
CN-110819665-A Preparation method of 6, 7, 8-trihydroxy coumarin 苏州大学 2020-02-21 CN disclosed
EP-2397511-B1 Polyester film and method for producing same, backsheet for solar cell, and solar cell module FUJIFILM CORP (JP) 2018-07-18 EP disclosed
US-6660767-B2 Such as coumarin, dicoumarol, 7-hydroxycoumarin (umbelliferone), 6,7- dihydroxycoumarin (exculetin), 3,6,7 trihydroxycoumarin, warfarin, or warfarin sodium; for treatment of cancer, Alzheimer's diseade, gout THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2003-12-09 US disclosed
WO-2003029237-A1 PRODUCTS OF CONDENSATIONS OF HYDROXYCOUMARIN DERIVATIVES WITH AROMATIC AND ALIPHATIC DIALDEHYDES, THEIR PREPARATION AND ANTIVIRAL ACTION THEREOF PLIVA, FARMACEUTSKA INDUSTRIJA, DIONICKO DRUSTVO (HR) 2003-04-10 WO disclosed
WO-2003029237-A1 PRODUCTS OF CONDENSATIONS OF HYDROXYCOUMARIN DERIVATIVES WITH AROMATIC AND ALIPHATIC DIALDEHYDES, THEIR PREPARATION AND ANTIVIRAL ACTION THEREOF PLIVA, FARMACEUTSKA INDUSTRIJA, DIONICKO DRUSTVO (HR) 2003-04-10 WO disclosed
EP-0598117-B1 BENZOPYRAN DERIVATIVE AND ANTIALLERGIC AGENT CONTAINING THE SAME AS ACTIVE INGREDIENT DAINIPPON INK & CHEMICALS (JP) 1999-06-30 EP disclosed
US-5428059-A Benzopyran derivatives and an anti-allergic agent possessing the same as the active ingredient DAINIPPON INK & CHEMICALS, INC. (JP) 1995-06-27 US disclosed
EP-0598117-A1 BENZOPYRAN DERIVATIVE AND ANTIALLERGIC AGENT CONTAINING THE SAME AS ACTIVE INGREDIENT DAINIPPON INK AND CHEMICALS, INC. (JP) 1994-05-25 EP disclosed